Location: Home
  • search
  • go
  • Relate News
  • 2/17/2022Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...
  • 2/17/2022Chinese Pharmaceutical Cross-Border M&A in 2022 (PharmExec)
  • 2/16/2022FDA Places Phase 1 Trial of Legend's Early-stage CAR-T on Hold
  • 2/16/2022SciNeuro and Alamar Collaborate to Discover Novel Therapeutic Antibodi...
  • 2/16/2022Organon Acquires Bayer's Contraceptive Products Marvelon and Mercilo...
  • 2/16/2022USTR: China Falling Short on WTO Compliance and New Trade Tools Are N...
  • 2/16/2022Information Collection on the 7th VBP Officially Initiated by the JPO
  • 2/16/2022CDE Issues the Technical Guidelines on Clinical Trial of Antiviral The...
  • 2/15/2022Snapshot of MNC Pharma's China Performance in 2021
  • 2/15/2022Moderna Announces Plan to Expand Footprint in Asia with Four Additiona...
  • 2/15/2022China Faces Fresh Health Crisis as Experts Discover Alarming Heart Con...
  • 2/15/2022ChinaBio Partnering Forum Acquired by EBD Group/Informa
  • 2/15/2022Lacking Revenue, Lepu Biopharma Chases IPO to Revive War Chest (The Ba...
  • 2/14/2022Chinese Drug Developers Look to Enter the U.S. Market through Out-lice...
  • 2/14/2022Bloomberg: China's Approval of Pfizer Pill Opens Door to Ending Its 'C...
  • 2/14/2022Takeda Vows to Expand Business and Investments in China
  • 2/14/2022Chinese CDMO Asymchem to Expand in the U.S. thru Acquisition of Snapdr...
  • 2/14/2022NHC Reorganizes, Integrating Relevant Jurisdictions and Departments wi...
  • 2/13/2022China Approves Pfizer's Covid Drug Paxlovid Conditionally
  • 2/13/2022State Council's Policy Briefing Confirms Accelerated Expansion of Cent...
  • 2/13/2022Innovent's Setback Warns Peers Prioritizing Pricing Not Good Tactic in...
  • 2/11/2022EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immu...
  • 2/11/2022AKSO and Huadong Medicine Enter Strategic Collaboration to Develop/Com...
  • 2/11/2022NMPA Issues the List of Reference Formulations for GQCE Studies (51st ...
  • 2/11/2022Drug R&D and Product Registration News Digest February 2022 (1)
  • 2/10/2022AstraZeneca Reports Q4 and FY 2021 Performance, China Revenue Surging ...
  • 2/10/2022CDE Issues the Q&As on Issues Related to Pharmaceutical Research and E...
  • 2/10/2022GSK Won Chinese Approval of Benlysta (belimumab) for Adult Patients wi...
  • 2/10/2022U.S. FDA Panel Recommends Additional Trial for Lilly/Innovent Lung Ca...
  • 2/10/2022China Is the Focus of AZ's Earnings Call for Q4 and FY 2021, BMI Fraud...
  • Page:149/774 Total number of articles:23208: [First][<<] [147] [148] [149] [150] [151] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group